For patients with non-small-cell lung cancer, a simple PET/CT protocol can enhance the precision of traditional staging, which could lead to more appropriate management, according to new research presented here at the Society of Nuclear Medicine and Molecular Imaging 2016 Annual Meeting. {read more here}

Non-small cell lung cancers (NSCLC) have a collective reputation for not responding very well to chemotherapy. Researchers at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) are presenting a means of evaluating an immunotherapy that fights off NSCLC by strengthening a patient’s own immune system. {read more here}

For the detection of metastases associated with endometrial cancer, overall accuracy is 88% with ¹⁸F-fluorodeoxyglucose PET integrated with CT (¹⁸F-FDG PET/CT), a systematic review and meta-analysis reveal. And for the detection of postsurgical recurrence, overall accuracy is 93%. {read more here}

PET amyloid imaging does a fine job finding susceptibility to Alzheimer’s disease long before symptoms set in, but PET tau imaging is better at showing what’s going on once neuronal injury becomes functionally evident. {read more here}